EUVIMEDEUVIMED entdecken
Open Access

Impact of Bevacizumab on Clinical Outcomes in Patients With Platinum-resistant Relapsed Ovarian Cancer

Aeran Seol, Se Ik Kim, Hee Yeun Yoon, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Noh Hyun Park, Yong Sang Song

In Vivo · 2024

DOI: 10.21873/invivo.13574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Aeran Seol und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Korea University Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Bevacizumab, Drug Resistance, Neoplasm, Ovarian Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BevacizumabDrug Resistance, NeoplasmOvarian NeoplasmsNeoplasm Recurrence, LocalAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMiddle AgedAgedAdultTreatment OutcomePrognosisRetrospective StudiesCarcinoma, Ovarian EpithelialPlatinumAntineoplastic Agents, Immunological

Stichwörter der Autor:innen

Epithelial ovarian cancerbevacizumabplatinum-resistantreal world experiencetreatment response

Substanzen

BevacizumabPlatinumAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Korea University Medical Center, Seoul, Republic of Korea.
  • Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea; marialeemd@gmail.com.
  • Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Obstetrics and Gynecology, Myongji Hospital, Goyang-si, Republic of Korea.

Zitieren

APA

Seol, A., Kim, S. I., Yoon, H. Y., Lee, M., Kim, H. S., Chung, H. H., Park, N. H., & Song, Y. S. (2024). Impact of Bevacizumab on Clinical Outcomes in Patients With Platinum-resistant Relapsed Ovarian Cancer. In Vivo. https://doi.org/10.21873/invivo.13574

Vancouver

Seol A, Kim SI, Yoon HY, Lee M, Kim HS, Chung HH, et al. Impact of Bevacizumab on Clinical Outcomes in Patients With Platinum-resistant Relapsed Ovarian Cancer. In Vivo. 2024. doi:10.21873/invivo.13574

BibTeX
@article{Seol2024,
  author = {Seol, Aeran and Kim, Se Ik and Yoon, Hee Yeun and Lee, Maria and Kim, Hee Seung and Chung, Hyun Hoon and Park, Noh Hyun and Song, Yong Sang},
  title = {Impact of Bevacizumab on Clinical Outcomes in Patients With Platinum-resistant Relapsed Ovarian Cancer},
  journal = {In Vivo},
  year = {2024},
  doi = {10.21873/invivo.13574}
}
Kostenlos starten →